Bacteriophage based test for the rapid detection & Antibiotic sensitivity test of TB Viro102: Bacteriophages & Phage Therapy 3 Credit hours NUST Centre.

Slides:



Advertisements
Similar presentations
TB 101 “Basic Facts on Tuberculosis”
Advertisements

TUBERCULOSIS This is the prompt slide for the TB Therapy section.
TB Disease and Latent TB Infection
Treatment of infectious diseases. Drugs used in the treatment of bacterial diseases can be grouped into categories based on their modes of action: 1.
TUBERCULOSIS Pulmonary TB.
Blood, transport and infections By Tibor Cemicky.
Tuberculosis Owhe Elo-Oghene Osewe. Tuberculosis This disease is caused by a microbe called mycobacterium tuberculosis. This bacterium is known to attacks.
Spinal Tuberculosis Abdullah Baghaffar. What Is Spinal Tuberculosis? Tuberculosis of the spine, also known as tuberculous spondylitis or Pott's Disease,
Pulmonary TB. BY PROF. AZZA ELMedany Dr. Ishfaq Bukhari.
Gram negative vs. Gram Positive
Anti-tuberculous drugs. Mycobacteria Slow-growing bacillusDormant forms in macrophages.
Resistance of Mycobacterium tuberculosis to antibiotics n This bacterium that causes tuberculosis has been one of the scourges of humankind Caused 25%
MICR 454L Emerging and Re-Emerging Infectious Diseases Lecture 7: M. tuberculosis Dr. Nancy McQueen & Dr. Edith Porter.
Disease Prevention Tuberculosis.
TUBERCULOSIS Paige Derouin. History Began infecting the first human ancestors as long as 500,000 years ago In 1882 – claimed the lives of 1 in 7 people.
This is a global infectious disease.
TUBERCULOSIS POTENTIAL CURES THROUGH SYNTHETIC BIOLOGY.
Overview  Background Information  Etiology  Epidemiology  Mode of Transmission  Clinical manifestation/systems  Diagnostic test  Treatment  Prevention/Control.
Part 1 Principles of resistance to antituberculosis drugs Module 10 1.
Mycobacterium species Acid fast bacilli - cell walls contain unusual glycolipids (e.g.mycolic acids)
Mycobacterium Tuberculosis Amber Garza Kaylee Stroud Jennifer Sanchez.
Batterjee Medical College. Dr. Manal El Said Mycobacterium tuberculosis Head of Medical Microbiology Department.
Pulmonary TB. BY PROF. AZZA EL- MEDANY Department of Pharmacology.
USE OF DRUGS AGAINST MICRO-ORGANISMS
DNA: The Information Molecule How did scientists use evidence to discover that the DNA molecule contains information?
Lab Identification Of Mycobacterium Tuberclosis
18.1 Studying Viruses and Prokaryotes KEY CONCEPT Infections can be caused in several ways.
ANTIGEN ANTIBODY Proteins that recognize and bind to antigens.
CHEMISTRY 2000 Topics of Interest #1: Blowing up Bacteria with Nitrogen Monoxide (NO)
American Journal of Respiratory and Critical Care Medicine 2000 Vol. 161, pp
Experiment seven Mycobacterium tuberculosis. Pathogenesis primary infection primary infection 1) lung infection secondary infection secondary infection.
Chemotherapy of Tuberculosis By Prof. Azza El-Medany.
Tuberculosis Case Study Presenter Xoliswa Poswa TB Laboratory, NHLS/CMID.
Staphylococcus bacteria in nose
The Acid Fast Cell Wall Dr. Jennifer Coetzee.
Pulmonary TB. BY PROF.  AZZA ELMedany OBJECTIVES  At the end of lecture, the students should:  Discuss the etiology of tuberculosis  Discuss the.
Mycobacterial, Fungal, & Parasitic Infections Medications for Infection ADN 110/cohort 131.
Gram Stain Differential stain (Hans Christian Gram, a Danish doctor ). He developed a new method to stain bacteria so they can be visible in specimen.
Chemotherapy Of Mycobacterial Infections Dr.Mohamed daood PhD student in Pharmacology.
Treatment of Infectious Diseases. ›Drugs used to treat bacterial diseases are grouped into categories based on their modes of action Treatment of Bacterial.
Ghada Barakat.  They are obligate aerobe, rod-shaped, non-motile, non-spore forming, non- capsulated organisms.  Impermeable to various basic dyes,
Jory Scott 12E Mycobacterium leprae: the leprosy pathogen.
Mycobacterium tuberculosis Klebsiella pneumoniae, Legionella pneumophila, Mycobacterium leprae.
MYCOBACTERIA Dr.Qurat-Ul-Ain Senior Demonstrator Microbiology, KEMU, Lahore.
INFECTIOUS BACTERIAL AIRBORNE DISEASES PULMONARY TUBERCULOSIS
Antimycobacterial Drugs September Mycobacteria Mycobacteria are intrinsically resistant to most antibiotics. Because they grow slowly compared with.
Tuberculosis. TB is a common infectious disease caused by the bacterium Mycobacterium tuberculosis. The bacteria usually affects the lungs but it can.
Chapter 20 Mycobacterium
Immunology and Infectious Diseases
Tuberculosis in children
Chapter 18: Viruses and Prokaryotes
Phage Based Diagnostic Systems
Principles of Laboratory Diagnosis of Infectious Diseases
Antibiotic Resistance
1 Drug susceptible TB Limited resistance MDR-TB (Frieden, 1993) XDR-TB
Mycobacterium tuberculosis Characteristics
Part 1 Principles of resistance to antituberculosis drugs
Tuberculosis Group: Kansas university
Vaccines, Viruses and the Immune System
Immunology & Public Health
Vaccines, Viruses and the Immune System
Treatment of Infectious Diseases
Viruses.
Digging Deeper into Bacteria
Investigate the Treatment of Infectious Diseases
Investigate the Treatment of Infectious Diseases
Tuberculosis.
assist. Prof. Zainab Abdul jabar Aldhaher
Basic diagnostic algorithm to link the molecular line probe assay with solid culture- and liquid culture-based growth detection and susceptibility testing.
Presentation transcript:

Bacteriophage based test for the rapid detection & Antibiotic sensitivity test of TB Viro102: Bacteriophages & Phage Therapy 3 Credit hours NUST Centre of Virology & Immunology

Tuberculosis (TB) is an infectious disease caused by bacteria Mycobacterium tuberculosis.Mycobacterium tuberculosis TB most commonly affects the lungs but also can involve almost any organ of the body. MTB is an obligate aerobic bacterium, therefore it needs oxygen to survive. The World Health Organization declared TB a global emergency in Since then, antibiotic resistant TB has been reported in 104 countries.

Tuberculosis combines one of the slowest division rates among bacteria with a hardy cell wall defense system. Both of these factors stretch treatment into a multiple month process, creating a massive window for human error in the form of incorrect or missed dosages. This slow pace of infection increases the possibility of evolution based antimicrobial resistance by giving tuberculosis bacteria time to mutate.

Cell Wall of MTB The cell wall of MTB is one of the major determining factors of its virulence. The structure of the cell wall has three major components: 1.mycolic acids, 2.cord factors, and 3.Wax-D. The mycolic acid molecules are of primary interest due to their deadly qualities. Mycolic acids create a lipid shield, which protects against cationic proteins, lysozyme, and oxygen radicals of phagocytosis.

Cell wall is impervious to gram staining due to the high content of lipids, especially mycolic acid. This characteristic places MTB in a category of bacterium known as acid fast bacteria, whose acid rich cell walls retain a red dye used for staining, despite attempts at decolorization ( Acid Fast Staining). The full genome of MTB was sequenced in Large amount of coding is dedicated to the genesis and lysis of lipids, compared to other bacteria. This explained why over 60 percent of the MTB cell wall is composed of lipids.

Antimicrobial Resistance The waxy, hydrophobic cell wall of MTB gives it the ability to survive long exposure to substances such as acids, detergents, oxidative bursts, and antibiotics. In fact, the typical “short” treatment of MTB involves a four antibiotic treatment for two months and then a two antibiotic treatment for an additional four months. The antibiotics involved are isoniazid, rifampicin, pyrazinamide, and ethambutol.

Isoniazid, are targeted at the synthesis of mycolic acids. Two types of drug resistant MTB strains are currently recognized. 1.Multi drug resistant tuberculosis (MDR TB) is resistant to at least two of the four first-line drugs listed above. 2.Extensively drug resistant tuberculosis (XDR TB) is defined as resistant to isoniazid, rifampin and also to fluoroquinolone and at least one of three injectable second line drugs.

How bacteriophage can be used? Principle Portions of decontaminated sputum incubated Bacteriophage (Actiphage) infect viable TB bacilli in sputum. A potent virucide (Virusol) destroys all bacteriophage that have not infected TB bacilli. Bacteriophage replicating in TB bacilli survive and are detected as plaques after plating with non pathogenic mycobacterial Sensor cells

Specimen processing Sputum or blood collection Decontaminate by NaOH method. Suspend pellet in 1.5ml Response Medium Plus. Centrifuge at minimum of 2000g for 20 mins Decant supernatant. Suspend in 1ml Response Medium Plus Add 0.5ml test suspension RIF- 0.5ml Response Medium Plus RIF+ 0.5ml Response Medium Plus Incubate both vessels for hours. (commence with

Incubate overnight at 37ºC Thanks